Free Trial

Pharvaris (PHVS) News Today

Pharvaris logo
$18.93 -0.64 (-3.27%)
(As of 05:26 PM ET)
Pharvaris stock logo
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $906,000 in Pharvaris (NASDAQ:PHVS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Pharvaris (NASDAQ:PHVS - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 48,896 shares of the company's stock,
Pharvaris price target lowered to $46 from $50 at JMP Securities
Pharvaris Reports Q3 2024 Progress and Financials
Oppenheimer Remains a Buy on Pharvaris (PHVS)
Pharvaris Advances in HAE Treatment with Strong Financials
Pharvaris’s Promising Developments in HAE Treatment Drive Buy Rating
Pharvaris (PHVS) Receives a Buy from Morgan Stanley
Oppenheimer Sticks to Their Buy Rating for Pharvaris (PHVS)
Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)
Pharvaris (PHVS) Gets a Buy from Morgan Stanley
Pharvaris stock logo
Novo Holdings A S Has $32.43 Million Stock Position in Pharvaris (NASDAQ:PHVS)
Novo Holdings A S raised its holdings in shares of Pharvaris (NASDAQ:PHVS - Free Report) by 47.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,725,000 shares of the company's stock after purchasing an
Morgan Stanley Keeps Their Buy Rating on Pharvaris (PHVS)
Pharvaris Presents Data at the Bradykinin Symposium 2024
Morgan Stanley Sticks to Its Buy Rating for Pharvaris (PHVS)
Morgan Stanley Sticks to Their Buy Rating for Pharvaris (PHVS)
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Gap Down to $19.08
Pharvaris (NASDAQ:PHVS) Shares Gap Down to $19.08
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Up 5.2%
Pharvaris (NASDAQ:PHVS) Shares Up 5.2%
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Stock Price Down 2.4%
Pharvaris (NASDAQ:PHVS) Shares Down 2.4%
Morgan Stanley Remains a Buy on Pharvaris (PHVS)
Oppenheimer Reaffirms Their Buy Rating on Pharvaris (PHVS)
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Up 5.1%
Pharvaris (NASDAQ:PHVS) Trading Up 5.1%
Pharvaris N.V. (9EN.SG)
Pharvaris Announces Annual Meeting of Shareholders
Wedbush Keeps Their Buy Rating on Pharvaris (PHVS)
Pharvaris stock logo
Pharvaris (NASDAQ:PHVS) Shares Up 8%
Pharvaris (NASDAQ:PHVS) Stock Price Up 8%
Pharvaris stock logo
Morgan Stanley Reiterates "Overweight" Rating for Pharvaris (NASDAQ:PHVS)
Morgan Stanley reaffirmed an "overweight" rating and issued a $34.00 target price on shares of Pharvaris in a report on Monday.
Get Pharvaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter.

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available 

PHVS Media Mentions By Week

PHVS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHVS
News Sentiment

0.92

0.59

Average
Medical
News Sentiment

PHVS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHVS Articles
This Week

1

1

PHVS Articles
Average Week

Get Pharvaris News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PHVS) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners